This website is in the process of being updated. Our full portfolio of products will be available on this page in due course. In the meantime, for safety and patient information relating to products not currently listed, please refer to the electronic Medicines Compendium website.
Showing refined by:
-
Ambirix (Hepatitis A and Hepatitis B vaccine)
Ambirix (Hepatitis A and Hepatitis B vaccine) links to the summary of product characteristics and patient information leaflet for UK members of the public -
Anoro▼ Ellipta (umeclidinium/vilanterol inhalation powder)
This page provides Anoro▼ Ellipta (umeclidinium/vilanterol) product overview and what it is used for, chronic obstructive pulmonary disease (COPD) -
Benlysta ▼ (belimumab) | GSK UK Public
Product information for UK patients prescribed Benlysta ▼ (belimumab) -
Bexsero, (Meningococcal group B Vaccine (rDNA, component, adsorbed)) | GSK Public site
Bexsero Meningitis B vaccine information for UK members of the public. -
Boostrix-IPV (diphtheria, tetanus, pertussis (acellular) and poliomyelitis (inactivated))
Boostrix-IPV links to the summary of product characteristics and patient information leaflet for UK members of the public -
Cervarix (Human Papillomavirus vaccine (Types 16, 18) (Recombinant, adjuvanted, adsorbed))
Human Papillomavirus vaccine (Types 16, 18) (Recombinant, adjuvanted, adsorbed) links to the summary of product characteristics and patient information leaflet for UK members of the public -
Dectova ▼ (zanamivir IV)
zanamivir IV links to the summary of product characteristics and patient information leaflet for UK members of the public -
Ellipta inhaler
A product overview of the Ellipta device for members of the UK public -
Engerix B (Hepatitis B vaccine)
ENGERIX B (Hepatitis B vaccine) links to the summary of product characteristics and patient information leaflet for UK members of the public -
Engerix B Paediatrics (Hepatitis B vaccine)
Engerix B Paediatrics (Hepatitis B vaccine) links to the summary of product characteristics and patient information leaflet for UK members of the public -
Fendrix (Hepatitis B vaccine)
Fendrix (Hepatitis B vaccine) links to the summary of product characteristics and patient information leaflet for UK members of the public -
Fluarix Tetra (influenza vaccine (split virion, inactivated))
influenza vaccine (split virion, inactivated) links to the summary of product characteristics and patient information leaflet for UK members of the public -
Haleraid | GSK public
Haleraid is a device developed to help patients with impaired hand agility administer a range of GSK inhalers. -
Havrix Junior Monodose (Hepatitis A vaccine)
Havrix Junior Monodose (Hepatitis A vaccine) links to the summary of product characteristics and patient information leaflet for UK members of the public -
Havrix Monodose (Hepatitis A vaccine)
Havrix Monodose (Hepatitis A vaccine) links to the summary of product characteristics and patient information leaflet for UK members of the public -
Infanrix-IPV +Hib (diphtheria tetanus pertussis (acellular) and hib vaccine)
Infanrix-IPV +Hib links to the summary of product characteristics and patient information leaflet for UK members of the public -
Menitorix (hib meningococcal group c combined vaccine)
Menitorix links to the summary of product characteristics and patient information leaflet for UK members of the public -
Menveo (Meningococcal Group ACWY vaccine)
Menveo (Meningococcal Group ACWY vaccine) links to the summary of product characteristics and patient information leaflet for UK members of the public -
Nucala (mepolizumab) | GSK UK public
What is Nucala (mepolizumab)? Nucala is an asthma medicine used to treat patients aged 6 years and above with severe eosinophilic asthma. -
Priorix (Measles, Mumps and Rubella vaccine (live))
Priorix links to the summary of product characteristics and patient information leaflet for UK members of the public -
Relenza (zanamivir)
zanamivir links to the summary of product characteristics and patient information leaflet for UK members of the public -
Rotarix (live attenuated rotavirus vaccine)
Rotarix links to the summary of product characteristics and patient information leaflet for UK members of the public -
Seretide (salmeterol xinafoate/fluticasone propionate)
Seretide product information and links to support UK patients who have been prescribed Seretide, and their carers. -
Trelegy▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol)
Trelegy▼ Ellipta (fluticasone furoate/umeclidinium/vilanterol) product information for the UK members of the public -
Twinrix (Hepatitis A and hepatitis B vaccine)
TWINRIX (Hepatitis A and hepatitis B vaccine) links to the summary of product characteristics and patient information leaflet for UK members of the public -
Twinrix Paediatrics (Hepatitis A and hepatitis B vaccine)
Twinrix Paediatrics (Hepatitis A and hepatitis B vaccine) links to the summary of product characteristics and patient information leaflet for UK members of the public -
Varilrix (Live attenuated varicella-zoster (Oka strain) virus)
Varilrix (Live attenuated varicella-zoster (Oka strain) virus) links to the summary of product characteristics and patient information leaflet for UK members of the public -
Zejula▼ (niraparib)
Information for members of public on Zejula (niraparib)
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
There are no results matching your refine settings
Show more
Other products
Content is provided on this website for products with a United Kingdom product licence. In some cases, content may be provided relating to products that have mutual recognition or national licence, which has been created for United Kingdom audiences.
Reporting of side effects. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/. By reporting side effects you can help provide more information on the safety of this medicine.
Additional note for medicines / vaccines with a black triangle:
▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See information in paragraph above to see how to report side effects.
S.S. July 2020. NP-GB-NA-WCNT-200024
